<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We examined whether <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> predicts incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> more effectively than impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (IFG) in a general Japanese population </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 1,935 nondiabetic subjects aged 40-79 years were followed-up prospectively for a mean of 11.8 years </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: During the follow-up, 286 subjects developed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Compared with those without <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, the multivariate-adjusted hazard ratio (HR) for incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was significantly higher in subjects of both sexes with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, even after adjustment for confounding factors, age, family history of <z:mp ids='MP_0002055'>diabetes</z:mp>, total cholesterol, alcohol intake, smoking habits, and regular exercise (men: HR 2.58 [95% CI 1.85-3.59]; women: 3.69 [2.58-5.27]) </plain></SENT>
<SENT sid="4" pm="."><plain>The multivariate-adjusted HR of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was slightly lower in men and similar in women compared with that of IFG </plain></SENT>
<SENT sid="5" pm="."><plain>The multivariate-adjusted HR for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> rose progressively as the number of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> components increased in both subjects with and without IFG </plain></SENT>
<SENT sid="6" pm="."><plain>In stratified analysis, the multivariate-adjusted risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was significantly higher in subjects with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> alone (2.37 [1.45-3.88]) or IFG alone (3.49 [2.57-4.74]) and markedly increased in subjects with both <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and IFG (6.76 [4.75-9.61]) than in subjects with neither <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> nor IFG </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, the multivariate-adjusted risk for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was also significantly higher in subjects with both <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and IFG than in those with either one alone (both P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Our findings suggest that <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> significantly increases the risk of incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, independent of IFG, and is therefore a valuable tool to identify individuals at high risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>